Mobile Menu

  • AboutUs_Normal-24 The EyeCRO Approach
    • About Us
    • Careers
    • Location
    • Partners
  • MiDrops MiDROPS™
  • InVivo Models
    • Allergic Conjunctivitis
    • Corneal Sensitivity
    • Corneal Wound Healing
    • Diabetic Keratopathy
    • DL-AAA Retinal Leakage
    • Dry Eye Disease
    • Endotoxin induced Uveitis
    • Experimental Autoimmune Uveitis
    • Geographic Atrophy
    • Inherited Retinal Degenerations
    • Ischemia Reperfusion Injury
    • Laser-induced Choroidal Neovascularization
    • Light Damaged
    • Mitochondrial Neuropathy
    • Optic Nerve Crush
    • Oxygen Induced Retinopathy
    • Retinal Detachment
    • Retinal Vein Occlusion
    • STZ-induced Diabetic Retinopathy
    • VEGF-induced permeability
  • InVitro Capabilities
    • A2E Quantification
    • Bioanalytical Detection
    • Biochemistry
    • Histology
    • Ophthalmic Imaging and Physiology
  • News News
  • ContactUs Contact Us
  • Menu
  • Skip to primary navigation
  • Skip to main content

https://eyecro.com

  • AboutUs_Normal-24 The EyeCRO Approach
    • About Us
    • Careers
    • Location
    • Partners
  • MiDrops MiDROPS™
  • InVivo Models
    • Allergic Conjunctivitis
    • Corneal Sensitivity
    • Corneal Wound Healing
    • Diabetic Keratopathy
    • DL-AAA Retinal Leakage
    • Dry Eye Disease
    • Endotoxin induced Uveitis
    • Experimental Autoimmune Uveitis
    • Geographic Atrophy
    • Inherited Retinal Degenerations
    • Ischemia Reperfusion Injury
    • Laser-induced Choroidal Neovascularization
    • Light Damaged
    • Mitochondrial Neuropathy
    • Optic Nerve Crush
    • Oxygen Induced Retinopathy
    • Retinal Detachment
    • Retinal Vein Occlusion
    • STZ-induced Diabetic Retinopathy
    • VEGF-induced permeability
  • InVitro Capabilities
    • A2E Quantification
    • Bioanalytical Detection
    • Biochemistry
    • Histology
    • Ophthalmic Imaging and Physiology
  • News News
  • ContactUs Contact Us

Preclinical Ophthalmic Contract Research

Experimental Autoimmune Uveitis

Uveitis can affect individuals of all ages, genders, and genetic backgrounds, and represents a major public health concern as one of the leading causes of vision loss.  Uveitis is an inflammatory disease of the uvea and can be broadly separated into “infectious” and “non-infectious” subtypes.  Non-infectious uveitis is often coincident with systemic autoimmune disorders with immune responses triggered by ocular antigens.   Current treatment options include corticosteroids and immunosuppressive drugs; however, these therapies are less than ideal due to multiple systemic side effects and insufficient efficacy in decreasing the severity of the disease.

At EyeCRO, experimental autoimmune uveitis (EAU) is induced in B10.RIII mice by immunization with the human IRBP peptide.  The presence of this peptide elicits a transient CD4+ T-cell mediated ocular autoimmune response, with a peak of the disease occurring from approximately 11 days to 18 days post-immunization.  The disease is monitored by measuring the optokinetic tracking (OKT) reflex to monitor visual function, funduscopic imaging to monitor ocular inflammation, and optical coherence tomography to quantify cell infiltrates into the vitreous.  Post-terminal analysis can include histology, multiplex analysis of ocular cytokine levels, and FACS analysis of T-cell induction.    

autoimmune uveitis data

© 2023 · EyeCRO · All Rights Reserved.